Homocysteine and methionine metabolism in renal failure

Seminars in Vascular Medicine

Volumn 5, Issue 2, 2005, Pages 201-208

  Van Guldener, Coen ^a   Stehouwer, Coen D A ^b,c  

^a AMPHIA HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Amino acid metabolism; Chronic renal failure; Homocysteine; Renal metabolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SULFATE;

AMINO ACID METABOLISM; GLOMERULUS FILTRATION RATE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; KIDNEY METABOLISM; METHYLATION; OXIDATION; REVIEW; SULFONATION; URINARY EXCRETION;

BIOLOGICAL MARKERS; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; METHIONINE; METHYLATION;

EID: 21744433687     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872405     Document Type: Review

References (56)

1. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000;58:353-362
2. Longenecker JC, Coresh J, Powe NR, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002;13:1918-1927
3. Sarnak MJ, Coronado BE, Greene T, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002;57:327-335
4. Henry RMA, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study. Kidney Int 2002;62:1402-1407
5. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002;13:745-753
6. Cohen BD, Patel H, Kornhauser RS. Alternate reasons for atherogenesis in uremia. Proc Clin Dial Transplant Forum 1977;7:178-180
7. Wilcken DEL, Gupta VJ. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest 1979;9:301-307
8. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128
9. Bostom AG, Shemin D, Verhoef P, et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. Arterioscler Thromb Vasc Biol 1997;17:2554-2558
10. Ducloux D, Motte G, Challier B, Gibey R, Chalopin JM. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol 2000;11:134-137
11. Mallamaci F, Zoccali C, Tripepi G, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002;61:609-614
12. Suliman ME, Qureshi R, Barany P, et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 2000;57:1727-1735
13. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 2004;15:442-453
14. Suliman ME, Stenvinkel P, Qureshi R, et al. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. Am J Kidney Dis 2004;44:455-465
15. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998;157(Suppl 2):S40-S44
16. Refsum H, Helland S, Ueland PM. Radioenzymic determination of homocysteine in plasma and urine. Clin Chem 1985;31:624-628
17. Stabler SP, Marcell PD, Podell ER, Allen RH. Quantitaten of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal Biochem 1987;162:185-196
18. Cusworth DC, Gattereau A. Inhibition of renal tubular reabsorption of homocystine by lysine and arginine. Lancet 1968;2:916-917
19. Falchuk ZM, Edwards WA, Laster L. Effects of alpha-aminoisobutyric acid on urinary excretion of homocystine in patients with homocystinuria. Metabolism 1973;22:605-610
20. Foreman JW, Wald H, Blumberg G, Pepe LM, Segal S. Homocystine uptake in isolated rat renal cortical tubules. Metabolism 1982;31:613-619
21. Sturman JA, Rassin DK, Gaull GE. Distribution of transsulphuration enzymes in various organs and species. Int J Biochem 1970;1:251-253
22. Gaull GE, von Berg W, Raiha NCR, Sturman JA. Development of methyltransferase activities of human fetal tissues. Pediatr Res 1973;7:527-S33
23. McKeever MP, Weir DG, Molloy A, Scott JM. Betaine-homocysteine methyltransferase: Organ distribution in man, pig, and rat and subcellular distribution in the rat. Clin Sci 1991;81:551-556
24. Hultberg B, Andersson A, Masson P, Larson M, Tunek A. Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest 1994;54:417-422
25. Ventura P, Panini R, Abbati G, Marchetti G, Salvioli G. Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy. Pharmacology 2003;68:105-114
26. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995;116:59-62
27. House JD, Brosnan ME, Brosnan JT. Renal uptake and excretion of homocysteine in rats with acute hyperhomocysteinemia. Kidney Int 1998;54:1601-1607
28. van Guldener C, Donker AJM, Jakobs C, Teerlink T, de Meer K, Stehouwer CDA. No net renal extraction of homocysteine in fasting humans. Kidney Int 1998;54:166-169
29. Garibotto G, Sofia A, Saffioti S, et al. Interorgan exchange of aminothiols in humans. Am J Physiol Endocrinol Metab 2003;284:E757-E763
30. Tsai MY, Aras O, Sozen H, et al. Plasma homocysteine levels in living kidney donors before and after uninephrectomy. J Lab Clin Med 2004;143:340-343
31. van Guldener C, Janssen MJFM, Stehouwer CDA, et al. The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function. Neth J Med 1998;52:58-64
32. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996;56:41-46
33. Francis ME, Eggers PW, Hostetter TH, Briggs JP. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 2004;66:303-312
34. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999;55:1028-1035
35. Ganji V, Kafai MR. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2003;77:826-833
36. Bostom AG. Homocysteine: "expensive creatinine" or important modifiable risk factor for arteriosclerotic outcomes in renal transplant recipients? J Am Soc Nephrol 2000;11:149-151
37. Samuelsson O, Lee DM, Attman PO, et al. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression. Nephron 1999;82:306-311
38. Sarnak MJ, Wang SR, Beck GJ, et al. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. Am J Kidney Dis 2002;40:932-939
39. Hovind P, Tarnow L, Rossing P, et al. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1. Am J Kidney Dis 2001;38:1376-1380
40. Ninomiya T, Kiyohara Y, Kubo M, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis 2004;44:437-445
41. Laidlaw SA, Berg RL, Kopple JD, Naito H, Walker WG, Walser M. Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the modification of diet in renal disease study. Am J Kidney Dis 1994;23:504-513
42. Allen RH, Stabler SP, Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 1993;42:1448-1460
43. Loehrer FMT, Angst CP, Brunner FP, Haefeli WE, Fowler B. Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant 1998;13:656-661
44. Herrmann W, Schorr H, Geisel J, Riegel W. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med 2001;39:739-746
45. Suliman ME, Anderstam B, Lindholm B, Bergstrom J. Total, free, and protein-bound sulphur amino acids in uraemic patients. Nephrol Dial Transplant 1997;12:2332-2338
46. Nakanishi T, Otaki Y, Hasuike Y, et al. Association of hyperhomocysteinemia with plasma sulphate and urine excretion in patients with progressive renal disease. Am J Kidney Dis 2002;40:909-915
47. Ducloux D, Aboubakr A, Motte G, et al. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12. Nephrol Dial Transplant 2002;17:865-870
48. Ghandour H, Bagley PJ, Shemin D, et al. Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of 1-folinic or folic acid. Kidney Int 2002;62:2246-2249
49. Suliman ME, Divino Filho JC, Barany P, Anderstam B, Lindholm B, Bergstrom J. Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients. J Am Soc Nephrol 1999;10:1287-1296
50. Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997;52:495-502
51. van Guldener C, Janssen MJ, de Meer K, Donker AJ, Stehouwer CD. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. J Intern Med 1999;245:175-183
52. van Guldener C, Kulik W, Berger R, et al. Homocysteine and methionine metabolism in ESRD: a stable isotope study. Kidney Int 1999;56:1064-1071
53. Stam F, van Guldener C, ter Wee PM, et al. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine. Am J Physiol Renal Physiol 2004;287:F215-F223
54. Perna AF, Ingrosso D, Galletti P, Zappia V, De Santo NG. Membrane protein damage and methylation reactions in chronic renal failure. Kidney Int 1996;50:358-366
55. Ingrosso D, Cimmioni A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003;361:1693-1699
56. Stam F, van Guldener C, ter Wee PM, Jakobs C, de Meer K, Stehouwer CDA. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease. Kidney Int 2005;67:259-264